These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8251383)

  • 1. Microenvironmentally dependent effects on murine haemopoiesis by a prolonged interleukin-1 treatment.
    de Haan G; Dontje B; Loeffler M; Nijhof W
    Br J Haematol; 1993 Sep; 85(1):15-9. PubMed ID: 8251383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.
    Johnson CS; Keckler DJ; Topper MI; Braunschweiger PG; Furmanski P
    Blood; 1989 Feb; 73(3):678-83. PubMed ID: 2783864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
    Goris H; Bungart B; Loeffler M; Schmitz S; Nijhof W
    Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of heme and IL-1 on hematopoietic stromal regeneration after radiation.
    Lutton JD; Chertkov JL; Jiang S; Kappas A; Levere RD; Abraham NG
    Am J Hematol; 1993 Nov; 44(3):172-8. PubMed ID: 8213766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
    Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
    Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
    In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
    Loeffler M; Bungart B; Goris H; Schmitz S; Nijhof W
    Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of the effects of the unpurified preparations of murine erythropoietin and human recombinant erythropoietin on erythroid and granulocyte-macrophage progenitor cells in semi-solid mouse bone marrow cultures].
    Manakova TE; Kapina MA
    Biull Eksp Biol Med; 1991 Aug; 112(8):176-9. PubMed ID: 1786383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice.
    Bungart B; Loeffler M; Goris H; Dontje B; Diehl V; Nijhof W
    Br J Haematol; 1990 Oct; 76(2):174-9. PubMed ID: 1709805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: experimental results and model analysis.
    de Haan G; Dontje B; Nijhof W; Loeffler M
    Stem Cells; 1995 Jan; 13(1):65-76. PubMed ID: 7536513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.